Kenia

Christmas is here once again!&nbsp;APR would like to take this chance to share a small gift with you and invite you to take part to a project we really care about.&nbsp;Thanks to our partner Treedom, each of you will have his own tree to be planted, as part of our APR Forest in Kenya.&nbsp;So, this year our Christmas trees will be dedicated to the planet and to those than need them the most.&nbsp;The forest which the trees will form a part of will have both local and global long-lasting benefits.&nbsp;So, hurry up: go and activate your personal code to give life to your Tree!&nbsp;We hope you appreciate this little gift.
Merry Christmas!

Christmas 2015

APR Applied Pharma Research s.a. ("APR&rdquo;) is a private, international corporation headquartered in Switzerland and focused on the development and licenses of innovative healthcare products addressing patients or consumer needs in selected therapeutic areas. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; APR with its innovative business model and network of international partners has a proven track record in developing branded and patented Rx and OTC products worldwide and offers late-stage licensing opportunities for internally developed Rx and OTC products, as well as it provides an integrated and complete range of contract R&amp;D services. APR mission is to identify, develop and license, on a global basis, science driven products designed to get to the core of patients' needs using "state of art" technology and innovative dosage forms and delivery systems.
APR has entered into licensing and partnership agreements with pharmaceutical companies in over 70 countries with international sales on a worldwide basis.

APR Applied Pharma Research sa

200

110,00 t*

1

1

APR Applied Pharma Research sa Bäume